| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 244.84B | 243.48B | 231.51B | 230.19B | 210.69B |
| Gross Profit | 96.63B | 93.74B | 89.95B | 86.06B | 85.21B |
| EBITDA | 36.42B | 33.15B | 30.84B | 31.14B | 31.19B |
| Net Income | 10.75B | 9.22B | 8.48B | 6.46B | 8.97B |
Balance Sheet | |||||
| Total Assets | 219.59B | 214.90B | 209.12B | 193.34B | 184.47B |
| Cash, Cash Equivalents and Short-Term Investments | 5.41B | 5.64B | 5.76B | 4.36B | 4.74B |
| Total Debt | 66.83B | 65.09B | 65.53B | 64.91B | 61.25B |
| Total Liabilities | 115.12B | 119.04B | 117.82B | 111.03B | 105.52B |
| Stockholders Equity | 101.92B | 93.47B | 89.08B | 80.22B | 77.24B |
Cash Flow | |||||
| Free Cash Flow | 9.45B | 11.43B | 13.09B | 6.97B | 7.25B |
| Operating Cash Flow | 27.22B | 25.80B | 30.08B | 21.23B | 20.84B |
| Investing Cash Flow | -17.41B | -15.83B | -19.15B | -14.46B | -14.90B |
| Financing Cash Flow | -10.07B | -10.13B | -9.36B | -7.19B | -6.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥177.28B | 10.76 | ― | 2.66% | -4.58% | 51.25% | |
71 Outperform | ¥139.24B | 13.21 | 9.14% | 2.84% | 6.97% | 28.34% | |
71 Outperform | ¥224.76B | 18.16 | ― | 3.90% | 1.23% | 11.14% | |
69 Neutral | ¥184.13B | 7.84 | 8.27% | 2.68% | 3.42% | 13.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥148.40B | 14.10 | ― | 3.17% | 0.56% | 17.01% | |
58 Neutral | ¥360.50B | 4.33 | 8.35% | 2.73% | -3.16% | -32.06% |